Xenon Pharmaceuticals Inc. Quarterly Current Ratio in % from Q2 2015 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Xenon Pharmaceuticals Inc. quarterly Current Ratio history and growth rate from Q2 2015 to Q3 2024.
  • Xenon Pharmaceuticals Inc. Current Ratio for the quarter ending September 30, 2024 was 2.48K %, a 10.1% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 2.48K +228 +10.1% Sep 30, 2024
Q2 2024 2.47K -144 -5.49% Jun 30, 2024
Q1 2024 2.37K -1.09K -31.5% Mar 31, 2024
Q4 2023 2.2K -2.12K -49.2% Dec 31, 2023
Q3 2023 2.25K -2.69K -54.4% Sep 30, 2023
Q2 2023 2.62K -1.79K -40.6% Jun 30, 2023
Q1 2023 3.46K +215 +6.63% Mar 31, 2023
Q4 2022 4.32K +1.77K +69.7% Dec 31, 2022
Q3 2022 4.94K +3.12K +171% Sep 30, 2022
Q2 2022 4.41K +2.82K +177% Jun 30, 2022
Q1 2022 3.25K +1.9K +141% Mar 31, 2022
Q4 2021 2.54K +1.74K +215% Dec 31, 2021
Q3 2021 1.83K +1.23K +204% Sep 30, 2021
Q2 2021 1.59K +1.05K +191% Jun 30, 2021
Q1 2021 1.35K +837 +163% Mar 31, 2021
Q4 2020 807 +162 +25.1% Dec 31, 2020
Q3 2020 601 -773 -56.3% Sep 30, 2020
Q2 2020 547 -1.38K -71.5% Jun 30, 2020
Q1 2020 512 -1.86K -78.4% Mar 31, 2020
Q4 2019 645 -1.64K -71.7% Dec 31, 2019
Q3 2019 1.37K -416 -23.2% Sep 30, 2019
Q2 2019 1.92K Jun 30, 2019
Q1 2019 2.37K Mar 31, 2019
Q4 2018 2.28K Dec 31, 2018
Q3 2018 1.79K Sep 30, 2018
Q4 2016 1.86K +1.1K +145% Dec 31, 2016
Q3 2016 1.94K +1.31K +209% Sep 30, 2016
Q2 2016 1.71K +1.23K +257% Jun 30, 2016
Q1 2016 1.13K Mar 31, 2016
Q4 2015 759 Dec 31, 2015
Q3 2015 628 Sep 30, 2015
Q2 2015 481 Jun 30, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.